|Articles|June 14, 2013
Strategic Outsourcing Debate
Lisa Henderson discusses the debate around aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Advertisement
Lisa Henderson on the debate surrounding strategic outsourcing, which is the aligning of sponsor and CRO in a more integrated way to run clinical trials from a project or portfolio standpoint and gain efficiencies and ultimately save money.
Additional links:
- April 2013 article,
Challenging the Value of Strategic Partnerships in Clinical Trial Outsourcing .
- PAREXEL's
Strategic Partnerships 2013 .
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5